xmas 2015, page-31

Thanks Hoyland.Thats all pretty much as I read it,just one other thing I noted..was that Calimmune hardly rates a mention in the presentations,so that supports the lack of upside in that deal.I'm certainly not trying to talk this down,but its a bit mind boggling to think a company could be in a position of having contributed an essential element to a HIV cure,but not really benefit financially,bit depressing actually. Anyway thanks for responding.Maxineamillion I'd be interested in your take on this,if you have time.